An evaluation of acetazolamide in chloroform hepatotoxicity.

[1]  R. M. James,et al.  CLINICAL EXPERIENCE WITH CHLOROFORM ANESTHESIA , 1960 .

[2]  O. Orth,et al.  A CLINICAL COMPARISON OF CHLOROFORM AND HALOTHANE BY A BLIND STUDY TECHNIQUE , 1960, Anesthesiology.

[3]  Rees Kr,et al.  Mechanism of action of carbon tetrachloride. , 1959 .

[4]  C. R. Stephen,et al.  HEPATOTOXICITY OF INHALATION ANESTHETIC DRUGS , 1958, Anesthesiology.

[5]  R. Lunt.  Delayed Chloroform Poisoning in Obstetric Practice , 1953, British medical journal.

[6]  M. Le,et al.  The influence of oxygen and carbon dioxide levels during anesthesia upon postsurgical hepatic damage. , 1951 .

[7]  Wilbur H. Miller,et al.  Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors1 , 1950 .

[8]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[9]  Tanturi Ca,et al.  Protective action of sulfanilamide on experimental chloroform hepatitis. , 1947 .

[10]  O. Gaebler.  Determination of bromsulphalein in normal, turbid, hemolyzed, or icteric serums. , 1945, American journal of clinical pathology.

[11]  A. Ivy,et al.  COMPARATIVE VALUE OF BROMSULPHALEIN, SERUM PHOSPHATASE, PROTHROMBIN TIME, AND INTRAVENOUS GALACTOSE TOLERANCE TESTS IN DETECTING HEPATIC DAMAGE PRODUCED BY CARBON TETRACHLORIDE. , 1944, The Journal of clinical investigation.

[12]  D. V. Slyke,et al.  STUDIES OF GAS AND ELECTROLYTE EQUILIBRIA IN BLOOD: XIII. THE DISTRIBUTION OF CHLORIDE AND BICARBONATE IN THE BLOOD OF NORMAL AND PATHOLOGICAL HUMAN SUBJECTS , 1928 .